Ovid Therapeutics Inc. (OVID) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH

6. NVDA
7. RKLB
8. MSFT
9. CRM
10. TGT

Price: $2.30 +4.07%

Revenue Growth %: -99.1%

Today's EPS Names:
PLCE, COE, JVA, More

Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q2 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.

Earnings

Earnings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!